Inhibrx Biosciences, Inc. (INBX) › Capital ExpendituresInhibrx Biosciences, Inc. (INBX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2023: $4.59M2024: $2.60M2025: $31.0K$31.0K2023Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$31.0K-98.8%2024$2.60M-43.5%2023$4.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share